Graphique du cours de l'action APUS
APUS Gagner
Apimeds Pharmaceuticals US Inc
$1.88
0%
$0
À la fermeture : Apr 16, 16:00:00 GMT-4
$1.88
0%
$0
Post-Marché: Apr 16, 18:08:31 GMT-4
Retour
Apimeds Pharmaceuticals US Inc (APUS) Gagner
Statistiques clés
Clôture préc.
$1.88
Prix d'ouverture
$1.69
Plage de la journée
$1.69 - $1.88
Plage de 52 semaines
$1.6 - $40.31
Volume
31.5K
Volume moyen
17.9K
Rendement en dividend
--
BPA (TTM)
--
Capitalisation boursière
$23.6M
Qu’est-ce que APUS ?
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. The company is headquartered in Matawan, New Jersey and currently employs 2 full-time employees. The company went IPO on 2025-05-09. The firm is engaged in developing Apitox, an intradermally administered bee venom-based toxin. The company is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.
